Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR. Chavoustie SE, et al. Among authors: mccloud p. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:13-18. doi: 10.1016/j.ejogrb.2019.11.032. Epub 2019 Nov 28. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31812702 Free article. Clinical Trial.
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.
Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A, McCloud P, Kinghorn GR. Waldbaum AS, et al. Among authors: mccloud p. PLoS One. 2020 May 4;15(5):e0232394. doi: 10.1371/journal.pone.0232394. eCollection 2020. PLoS One. 2020. PMID: 32365097 Free PMC article. Clinical Trial.
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Rice ASC, Dworkin RH, McCarthy TD, Anand P, Bountra C, McCloud PI, Hill J, Cutter G, Kitson G, Desem N, Raff M; EMA401-003 study group. Rice ASC, et al. Among authors: mccloud pi. Lancet. 2014 May 10;383(9929):1637-1647. doi: 10.1016/S0140-6736(13)62337-5. Epub 2014 Feb 5. Lancet. 2014. PMID: 24507377 Clinical Trial.
Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness-A Multisite Randomized Placebo Controlled Trial.
Ferreira DH, Louw S, McCloud P, Fazekas B, McDonald CF, Agar MR, Clark K, McCaffrey N, Ekström M, Currow DC; Australian National Palliative Care Clinical Studies Collaborative (PaCCSC). Ferreira DH, et al. Among authors: mccloud p. J Pain Symptom Manage. 2020 Mar;59(3):581-589. doi: 10.1016/j.jpainsymman.2019.10.017. Epub 2019 Oct 23. J Pain Symptom Manage. 2020. PMID: 31655189 Free article. Clinical Trial.
Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D, Louw S, McCloud P, Fazekas B, Plummer J, McDonald CF, Agar M, Clark K, McCaffrey N, Ekström MP; Australian National Palliative Care Clinical Studies Collaborative (PaCCSC). Currow D, et al. Among authors: mccloud p. Thorax. 2020 Jan;75(1):50-56. doi: 10.1136/thoraxjnl-2019-213681. Epub 2019 Sep 26. Thorax. 2020. PMID: 31558624 Clinical Trial.
67 results